Group 1 - The announcement pertains to the equity change of Jiangzhong Pharmaceutical Co., Ltd. by its controlling shareholder and its concerted parties, indicating a change that touches the 1% threshold [1][4]. - The controlling shareholder, China Resources Jiangzhong Pharmaceutical Group Co., Ltd. (referred to as "China Resources Jiangzhong"), plans to increase its shareholding in the company within 12 months starting from October 22, 2024, with a minimum investment of 60 million RMB and a maximum of 120 million RMB [4][5]. - As of the announcement date, China Resources Jiangzhong has cumulatively increased its shareholding by 2,784,350 shares, accounting for approximately 0.44% of the total share capital, with a total investment of 60,002,129.20 RMB [5][6]. Group 2 - The company completed the first registration of the second phase of its restricted stock incentive plan on June 6, 2025, which involved granting 6,128,000 shares, resulting in a change in total share capital from 628,868,022 shares to 634,996,022 shares [6]. - The shareholding percentage of China Resources Jiangzhong and its concerted parties decreased from 43.25% to 42.84% due to the stock incentive plan [6]. - The equity change does not result in a change of the controlling shareholder or actual controller of the company [6].
江中药业股份有限公司关于控股股东及其一致行动人权益变动触及1%刻度的提示性公告